{"nctId":"NCT00460746","briefTitle":"Enfuvirtide/Current Protease Inhibitor Switch to PREZISTA (Darunavir)/Ritonavir + TMC125 in HIV Patients With Enfuvirtide Side Effects.","startDateStruct":{"date":"2007-05"},"conditions":["HIV"],"count":10,"armGroups":[{"label":"001","type":"EXPERIMENTAL","interventionNames":["Drug: TMC125, Darunavir; Ritonavir"]}],"interventions":[{"name":"TMC125, Darunavir; Ritonavir","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Documented HIV-1 positive\n* History of drug resistance or antiretroviral failure while receiving each of three drug classes: Nucleoside Reverse Transcriptase Inhibitors (NRTIs), Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs) and (protease inhibitors) PIs\n* On a PI containing regimen with enfuvirtide with HIV viral load (VL) \\< 400 copies/mL for 6 months or longer\n* Continuously using the same PI regimen for 4 months prior to Screening\n* Decline to continue enfuvirtide or their physician recommends discontinuation due to injection site reactions that persist despite optimal technique and training with available methods of administration or loss of sites for injection due to tissue nodules and hardening.\n\nExclusion Criteria:\n\n* No use of any drug contraindicated in the current US package insert for PREZISTA (darunavir) or in the investigators brochure for TMC125\n* No prior or current therapy with PREZISTA (darunavir) or TMC125\n* No prior genotypic results demonstrating 3 or more darunavir resistance-associated mutations associated with diminished response to darunavir (V11I, V32I, L33F, I47V, I50V, I54L, I54M, G73S, L76V, I84V or L89V). Patients with \\> 3 darunavir resistance-associated mutations with available darunavir phenotypes, may be enrolled if the resistance phenotype demonstrates: Fold Change (FC) \\<10 to darunavir by PhenoSense GT (Monogram Biosciences) or FC \\<10 to darunavir by Antivirogram (Virco, BVBA) or FC \\<3.4 to darunavir by vircoTYPE (Virco BVBA)\n* AST or ALT \\>5 times ULN\n* Calculated CrCl \\< 30 ml/min.","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Proportion of Patients Who Maintain Plasma HIV Viral Load Measurements < 400 Copies/ml at 2, 4, 8, 12, 16, 24, 36 and 48 Weeks After Switching to DRV/r and ETR, Missing Equals Failure.","description":null,"paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"100","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"100","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"100","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"90","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"80","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"90","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"90","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"90","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"80","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"90","spread":null}]}]}]},{"type":"SECONDARY","title":"Proportion of Patients Who Have Viral Load Measurements <50 Copies/ml at 2, 4, 8, 12, 16, 24, 36 and 48 Weeks After Switching to DRV/r and ETR, Missing Equals Failure.","description":null,"paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"100","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"90","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"90","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"90","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"80","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"90","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"90","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"90","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"80","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"90","spread":null}]}]}]},{"type":"SECONDARY","title":"CD4+ Cell Count (x 10^6 Cell/L): Baseline and Median Changes From Baseline at 4, 8, 12, 16, 24, 36 and 48 Weeks.","description":null,"paramType":"MEDIAN","dispersionType":"Full Range","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"301.0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-12.0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-32.0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-17.0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-7.0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"19.0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"38.0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"63.5","spread":null}]}]}]},{"type":"SECONDARY","title":"CD4+ Cell Count (x 10^6 Cell/L): Baseline and Mean Changes From Baseline at 4, 8, 12, 16, 24,36 and 48 Weeks.","description":null,"paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"338.3","spread":"135.91"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.3","spread":"31.22"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-25.0","spread":"72.04"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-18.9","spread":"44.25"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.5","spread":"53.58"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"24.5","spread":"34.00"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"22.7","spread":"58.84"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"47.3","spread":"48.03"}]}]}]},{"type":"SECONDARY","title":"Median Change From Baseline in Triglycerides at Week 48.","description":null,"paramType":"MEDIAN","dispersionType":"Full Range","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"229.0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-24.5","spread":null}]}]}]},{"type":"SECONDARY","title":"Median Change From Baseline in Total Cholesterol at Week 48.","description":null,"paramType":"MEDIAN","dispersionType":"Full Range","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"189.0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-27.5","spread":null}]}]}]},{"type":"SECONDARY","title":"Median Change From Baseline in LDL Cholesterol at Week 48.","description":null,"paramType":"MEDIAN","dispersionType":"Full Range","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"100.0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-9.0","spread":null}]}]}]},{"type":"SECONDARY","title":"Median Change From Baseline in HDL Cholesterol.","description":null,"paramType":"MEDIAN","dispersionType":"Full Range","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"47.5","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-2.5","spread":null}]}]}]},{"type":"SECONDARY","title":"Median Change From Baseline in Total Cholesterol (TC) / High Denisty Lipoprotein (HDL) Ratio at Week 48.","description":null,"paramType":"MEDIAN","dispersionType":"Full Range","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"4.7","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.3","spread":null}]}]}]},{"type":"SECONDARY","title":"Median Change From Baseline in Glucose at Week 48.","description":null,"paramType":"MEDIAN","dispersionType":"Full Range","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"92.5","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.0","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":1,"n":10},"commonTop":["Fatigue","Diarrhea","Headache","Rash","Depression"]}}}